GNH India Pharmaceuticals Limited — Actinomycin Exporter Profile
Indian Pharmaceutical Exporter · #5 for Actinomycin · $53.4K export value · DGFT Verified
GNH India Pharmaceuticals Limited is the #5 Indian exporter of Actinomycin with $53.4K in export value and 56 verified shipments. GNH India Pharmaceuticals Limited holds a 1.8% market share in Actinomycin exports across 4 countries. The company exports 11 pharmaceutical products worth $1.8M across 3 therapeutic categories.
GNH India Pharmaceuticals Limited — Actinomycin Export Profile: Buyers & Destinations
Where Does GNH India Pharmaceuticals Limited Export Actinomycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $47.7K | 51 | 89.4% |
| ESTONIA | $2.7K | 2 | 5.1% |
| PERU | $2.6K | 2 | 4.9% |
| URUGUAY | $371 | 1 | 0.7% |
GNH India Pharmaceuticals Limited exports Actinomycin to 4 countries. The largest destination is BRAZIL accounting for 89.4% of GNH India Pharmaceuticals Limited's Actinomycin shipments. These destinations reflect GNH India Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.